loading-logo
press_release_image

Gaucher's Disease Treatment Market is Expected to Reach $ 1.67 bn by 2026

The Gaucher’s Disease Treatment Market was valued at US$1.51 billion in the year 2018 and is estimated to reach US$1.67 billion by 2026, at a CAGR of 1.22%. Gaucher’s Disease (GD), is an autosomal recessive disorder characterized by the accumulation of fatty substances especially in the liver, spleen, lungs, kidney and bone marrow d...   Read More

12 November, 2019

press_release_image

Chronic Obstructive Pulmonary Disease Drugs Market is Expected to Reach $ 14.27 bn by 2026

The Chronic Obstructive Pulmonary Disease (COPD) was valued at US $10.78 billion in the year 2018 and is estimated to reach US $14.27 billion by 2026, at a CAGR of 3.57%. Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory lung disease that causes airflow obstruction and breathing difficulties. COPD is characterized by emphys...   Read More

12 November, 2019

press_release_image

Acute Myeloid Leukemia Therapeutics Market is Expected to Reach $ 2.6 bn by 2026

The Global Acute Myeloid Leukemia Therapeutics Market was valued at US$754.38 Million in the year 2018 and is estimated to reach US$2.6 billion by 2026, at a CAGR of 16.9%. Acute Myeloid Leukemia (AML) is one of the most commonly occurring leukemias and accounts for approximately 80% of the leukemia related deaths worldwide. AML is a geneticall...   Read More

16 September, 2019

press_release_image

Multiple Myeloma Treatment Market is Expected to Reach $ 17.5bn by 2026

The Global Multiple Myeloma Treatment Market was valued at US$10.9 billion in the year 2018 and is likely to reach US$17.5 billion by 2026, with a CAGR of 6.1%. Multiple Myeloma is a type of blood cancer that is characterized by cancer formation in the white blood cells otherwise denoted as the plasma cells. Generally, antibodies are produced ...   Read More

13 September, 2019

press_release_image

Liquid Handling Systems Market is Expected to Reach $6.1 bn by 2026

The Liquid Handling Systems Market reached US$3.13 billion at the end of 2018 and is set to reach US$6.01 Billion at the end of 2026, with a CAGR of 8.5%. Generally, liquid handling systems are implemented in clinical laboratories and life science laboratories to reduce the time involved in sample processing, avoid spillages during dispensing, ...   Read More

11 September, 2019

press_release_image

Schizophrenia Drugs Market is Expected to Reach $8.3 bn by 2026

The Global Schizophrenia Drugs Market was valued at US$6.66 billion in the year 2018 and is expected to reach US$8.3 billion by 2026, at a CAGR of 2.79%. Schizophrenia, a disorder of the central nervous system is characterized by the disorientation of thinking, emotions, perceptions, language, etc. It is classified as positive, negative and co...   Read More

11 September, 2019

press_release_image

Urinary Stones Treatment Devices Market is Expected to Reach $1.98 bn by 2026

The Global Urinary Stones Treatment Devices Market was valued at US$1.48 billion in the year 2018 and is expected to reach US$1.98 billion by 2026, at a CAGR of 4.4%. Urinary stones are mainly formed due to the inability of an individual to empty the urinary bladder. Due to urine accumulation, the minerals in the concentrated urine start cryst...   Read More

10 September, 2019

press_release_image

Global Cell Therapy Market is Expected to Reach $8.21 bn by 2026

The Global Cell Therapy Market was valued at US$3.06 billion in the year 2018 and is expected to reach US$8.21 billion by 2026, at a CAGR of 13.1%. Cell therapy offers the promise of treating and altering the course of diseases which cannot be addressed adequately by the existing therapeutic modalities. Initially, blood transfusion was conside...   Read More

06 September, 2019

press_release_image

Global Sleep Apnea Devices Market is Expected to Reach $8.83 bn by 2026

The Sleep Apnea Devices Market reached US$5.1 billion at the end of 2018 and is set to stride over US$8.83 Billion at the end of 2026, with a CAGR of 7.1%. With more than one billion people suffering from sleep apnea, it has become one of the major disorders in recent times. Sleep Apnea is a potential sleep disorder characterized by the repeate...   Read More

05 September, 2019

press_release_image

Global Migraine Drugs Market is Expected to Reach $8.2 bn by 2026

The Global Migraine Drugs Market was valued at US$3.9 billion in the year 2018 and is expected to reach US$8.2 billion by 2026, at a CAGR of 9.73%. Migraine Drugs are a group of medication that is given for the relief of symptoms associated with migraine pain. Around 18 to 19 % of the global populace complain of frequent chronic headaches. In ...   Read More

05 September, 2019